000 01392 a2200385 4500
005 20250517103311.0
264 0 _c20190509
008 201905s 0 0 eng d
022 _a1552-4957
024 7 _a10.1002/cyto.b.21397
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aChandran, P Anoop
245 0 0 _aValidation of Immunomonitoring Methods for Application in Clinical Studies: The HLA-Peptide Multimer Staining Assay.
_h[electronic resource]
260 _bCytometry. Part B, Clinical cytometry
_c03 2018
300 _a342-353 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aCD8-Positive T-Lymphocytes
_ximmunology
650 0 4 _aHLA Antigens
_ximmunology
650 0 4 _aHumans
650 0 4 _aImmunoassay
_xmethods
650 0 4 _aImmunotherapy
_xmethods
650 0 4 _aPeptides
_ximmunology
650 0 4 _aReproducibility of Results
650 0 4 _aSensitivity and Specificity
650 0 4 _aStaining and Labeling
_xmethods
700 1 _aLaske, Karoline
700 1 _aCazaly, Angelica
700 1 _aRusch, Elisa
700 1 _aSchmid-Horch, Barbara
700 1 _aRammensee, Hans-Georg
700 1 _aOttensmeier, Christian H
700 1 _aGouttefangeas, Cécile
773 0 _tCytometry. Part B, Clinical cytometry
_gvol. 94
_gno. 2
_gp. 342-353
856 4 0 _uhttps://doi.org/10.1002/cyto.b.21397
_zAvailable from publisher's website
999 _c26176910
_d26176910